These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1785185)

  • 21. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse.
    Charles PC; Trgovcich J; Davis NL; Johnston RE
    Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
    Arya SC; Agarwal N
    Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-factorial specification of virus-host interactions: studies with strains of Venezuelan equine encephalomyelitis virus in mice.
    Walder R; Bradish CJ
    J Gen Virol; 1979 Aug; 44(2):373-82. PubMed ID: 521796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Tonate virus (subtype IIIB of the Venezuelan equine encephalitis complex) with encephalitis in a human.
    Hommel D; Heraud JM; Hulin A; Talarmin A
    Clin Infect Dis; 2000 Jan; 30(1):188-90. PubMed ID: 10619752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of Venezuelan equine encephalitis.
    Taylor KG; Paessler S
    Vet Microbiol; 2013 Nov; 167(1-2):145-50. PubMed ID: 23968890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate.
    Hart MK; Caswell-Stephan K; Bakken R; Tammariello R; Pratt W; Davis N; Johnston RE; Smith J; Steele K
    Vaccine; 2000 Jul; 18(26):3067-75. PubMed ID: 10825611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extension of the mean time to death of mice with a lethal infection of Venezuelan equine encephalomyelitis virus by antithymocyte serum treatment.
    Woodman DR; McManus AT; Eddy GA
    Infect Immun; 1975 Nov; 12(5):1006-11. PubMed ID: 1104481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radial haemolysis in gel used in serological studies on Venezuelan equine encephalomyelitis virus.
    Gaidamovich SY; Melnikova EE; Obukhova VR
    Acta Virol; 1981 Jan; 25(1):36-40. PubMed ID: 6112864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV
    Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of the therapeutic and prophylactic actions of immunomodulators in experimental infection due to the causative agent of Venezuelan equine encephalomyelitis].
    Bulychev LE; Sergeeva AN; Ryzhikov AB; Kotliarov LA; Poryvaev VD; Pliasunov IV
    Antibiot Khimioter; 1995 May; 40(5):28-31. PubMed ID: 8534176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venezuelan equine encephalitis virus: comparison of infectivity and virulence of strains V-38 and P676 in donkeys.
    Mackenzie RM; de Siger J; Parra D
    Am J Trop Med Hyg; 1976 May; 25(3):494-9. PubMed ID: 937636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HeN mice.
    Taylor K; Kolokoltsova O; Patterson M; Poussard A; Smith J; Estes DM; Paessler S
    Vaccine; 2012 Jun; 30(27):4095-105. PubMed ID: 22525795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-protective immunity between equine encephalomyelitis viruses in equids.
    Walton TE; Jochim MM; Barber TL; Thompson LH
    Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of Complete Equine Encephalitis Virus Genome from Human Swab Specimen, Peru.
    Juarez D; Guevara C; Wiley M; Torre A; Palacios G; Halsey ES; Ampuero S; Leguia M
    Emerg Infect Dis; 2018 Aug; 24(8):1578-1580. PubMed ID: 30016240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The detection of antibodies to the Venezuelan equine encephalomyelitis virus by immunoenzyme analysis using antigen purified in a water-polymer system].
    Pomelova VG; Bychenkova TA; Lavrova NA; Mel'nikova EE; Buĭnitskaia OB; Gaĭdomovich SIa; Khramov EN
    Vopr Virusol; 1991; 36(6):486-9. PubMed ID: 1785184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization].
    Sviatchenko VA; Kiselev NN; Ryzhikov AB; Bulychev LE; Mikriukova TP; Netesov SV
    Vopr Virusol; 2000; 45(6):38-41. PubMed ID: 11200645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.